Edition:
United States

Axovant Sciences Ltd (AXON.OQ)

AXON.OQ on NASDAQ Stock Exchange Global Select Market

2.10USD
2:33pm EDT
Change (% chg)

$0.17 (+8.81%)
Prev Close
$1.93
Open
$1.93
Day's High
$2.10
Day's Low
$1.93
Volume
63,787
Avg. Vol
789,540
52-wk High
$27.93
52-wk Low
$1.02

Chart for

About

Axovant Sciences Ltd. is a clinical-stage biopharmaceutical company. The Company is focused on acquiring, developing and commercializing therapeutics for the treatment of dementia, including Alzheimer's disease and Lewy body dementia. The Company intends to develop a pipeline of product candidates to address the cognitive,... (more)

Overall

Beta: --
Market Cap(Mil.): $235.62
Shares Outstanding(Mil.): 122.08
Dividend: --
Yield (%): --

Financials

  AXON.OQ Industry Sector
P/E (TTM): -- 103.50 32.14
EPS (TTM): -1.90 -- --
ROI: -126.82 1.52 12.66
ROE: -176.01 0.25 14.84

Competitors

  Price Chg
Acorda Therapeutics Inc (ACOR.OQ) $17.60 +0.20
Suven Life Sciences Ltd. (SUVP.NS) Rs301.75 -12.20

Earnings vs. Estimates